Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of ultrarapid acting insulin

Use of ultrarapid acting insulin

US Patent 11013788 · Granted May 25, 2021

Estimated economic value: $7,750,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of ultrarapid acting insulin2025
Use of ultrarapid acting insulin2025
Method of treating diabetes type 2 by administering ultrarapid acting insulin2024
Method of treating diabetes type 2 by administering ultrarapid acting insulin2024
Use of ultrarapid acting insulin2024
Use of ultrarapid acting insulin2024
Use of ultrarapid acting insulin2023
Use of ultrarapid acting insulin2023
Method of treating diabetes type 2 by administering ultrarapid acting insulin2020
Method of treating diabetes type 2 by administering ultrarapid acting insulin2020
Use of ultrarapid acting insulin2020
Use of ultrarapid acting insulin2020